Anika Therapeutics Inc. (ANIK)

HEALTH CARE: HEALTH CARE SUPPLIES
SIC: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS

32 WIGGINS AVENUE BEDFORD, MA 01730

Anika Therapeutics Inc. develops, manufactures and commercializes therapeutic products and devices intended to promote the protection and healing of bone, cartilage and soft tissue. These products are based on hyaluronic acid, a naturally occurring, biocompatible polymer found throughout the body.

Data based on most recent fiscal year report
Market Cap654.85 Million Shares Outstanding14.27 Million Avg Volume235.709 Thousand
1-Yr BETA vs S&P TR0.63 Current Ratio17.98 Quick Ratio16.09
View SEC Filings from ANIK instead.

View recent insider trading info

Funds Holding ANIK (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding ANIK BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

BOWER JOSEPH L.

  • Director
13,010 2019-11-27 3

BLANCHARD CHERYL R

  • Director
0 2019-11-20 1

CHEUNG SYLVIA CHIEF FINANCIAL OFFICER

  • Officer
47,741 2019-11-06 3

FINNERTY THOMAS EVP HUMAN RESOURCES

  • Officer
6,128 2019-10-30 2

HAGUE RICHARD CHIEF OPERATING OFFICER

  • Officer
335,021 2019-10-28 2

VOGT SUSAN L N

  • Director
16,000 2019-10-01 1

LARSEN GLENN R.

  • Director
7,590 2019-08-28 2

THOMPSON JEFFERY S

  • Director
6,842 2019-08-08 2

LAND RAYMOND J

  • Director
11,992 2019-07-29 2

DARLING JOSEPH G PRESIDENT AND CEO; DIRECTOR

  • Officer
  • Director
20,289 2019-07-27 3

LOEROP JAMES EVP BUSINESS DEVELOPMENT

  • Officer
0 2019-07-08 2

WHEELER STEVE E

  • Director
0 2019-07-01 0

AHN EDWARD S. CHIEF TECH & STRATEGY OFFICER

  • Officer
0 2019-02-26 2

SHERWOOD CHARLES H CEO AND DIRECTOR

  • Officer
  • Director
0 2018-03-02 0

ALEXANDER DANA M. CHIEF OPERATIONS OFFICER

  • Officer
0 2017-01-27 0

MASCIOLI STEPHEN R. CHIEF MEDICAL OFFICER

  • Officer
0 2016-04-04 0

MORAN JOHN C

  • Director
14,803 2015-08-07 0

LUPPINO FRANCESCO J CHIEF OPERATING OFFICER

  • Officer
0 2015-02-03 0

BARNETT CAROL A CHIEF COMMERCIAL OFFICER

  • Officer
6,100 2014-01-27 0

SHEETS JOHN W JR CHIEF SCIENTIFIC OFFICER

  • Officer
0 2013-10-02 0

FIDIA FARMACEUTICI S.P.A.

  • 10% Owner
No longer subject to file 2013-08-06 0

FIDIA FARMACEUTICI S.P.A.

P&R S.P.A.

FIORE HOLDING S.R.L.

  • 10% Owner
No longer subject to file 2013-08-06 0

QUINLAN KEVIN W CHIEF FINANCIAL OFFICER

  • Officer
27,112 2013-03-27 0

DAVIDSON EUGENE A

  • Director
71,763 2011-01-18 0

MRACHEK WILLIAM VICE PRESIDENT, HUMAN RESOURCE

  • Officer
0 2011-01-18 0

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5
No current insider transactions
Click here to report any possible errors with this stock listing.

Elevate your investments